Skip to main content

Allogene Therapeutics, Inc.

ALLONASDAQ
$1.46-0.04 (-2.67%)as of Oct 6, 2026
Legend
Insider buy
Insider sell
Congress buy
Congress sell
Hedge Funds
bought vs sold
Greener markers show more buyers; redder markers show more sellers.
Company share activityNet buybacksNo changeNet dilution
Marker size reflects transaction size.
  • Insider buy
  • Insider sell
  • Congress buy
  • Congress sell
  • Hedge Funds bought vs sold
Share activityNet buybacksNo changeNet dilution

Marker size reflects transaction size. Greener fund markers mean more buyers.

  • Insider Buy
  • Insider Sell
  • Congress Buy
  • Congress Sell
  • Hedge funds bought vs sold
  • BuybackNo changeNet dilution

Allogene Therapeutics, Inc. price and activity chart data

Showing the 1Y range: Oct 6, 2025 to Oct 6, 2026. Price (+5.8%). 0 insider or congressional trades plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding

Largest institutional holders

13F · Q2 2026
Fund% of company heldValue% of portfolioQuarterly activity
BlackRock, Inc.8.73%$62.7M0.00%Not reported
Frazier Life Sciences Management, L.P.6.50%$46.7M1.02%Add 491.22%
Pfizer Inc6.38%$46.9M27.55%Not reported
State Street Corp5.51%$39.6M0.00%Not reported
TPG GP A, LLC5.42%$38.9M0.78%Not reported
Sio Capital Management, LLC3.86%$27.7M4.59%New Not reported
Primecap Management Co3.80%$27.3M0.02%Add 56.61%
Vanguard Capital Management LLC3.52%$25.3M0.00%Not reported
FMR LLC3.48%$25M0.00%Not reported
Citadel Advisors LLC2.92%$21M0.00%Not reported
Two Sigma Investments, LP2.25%$16.2M0.01%Not reported
Geode Capital Management, LLC2.04%$14.7M0.00%Not reported
Goldman Sachs Group Inc1.78%$12.8M0.00%Not reported
GordonMD Global Investments LP1.53%$11M5.33%Add 270.49%
Marshall Wace, LLP1.48%$10.6M0.01%Not reported
Patient Square Capital LP1.46%$10.5M1.63%Add 46.38%
Aberdeen Group plc1.45%$10.4M0.01%Add 242.07%
Millennium Management LLC1.40%$10.1M0.00%Not reported
D. E. Shaw & Co., Inc.1.36%$9.8M0.00%Not reported
Morgan Stanley1.31%$9.38M0.00%Not reported
Woodline Partners LP1.30%$9.36M0.03%Not reported
Vanguard Portfolio Management LLC1.22%$8.76M0.00%Not reported
Renaissance Technologies LLC1.11%$7.98M0.01%Not reported
Walleye Capital LLC0.95%$6.8M0.02%Not reported
RTW Investments, LP0.94%$6.76M0.06%New Not reported
Dimensional Fund Advisors LP0.94%$6.74M0.00%Not reported
Bank of America Corp0.92%$6.63M0.00%Not reported
UBS Group AG0.88%$6.32M0.00%Not reported
Ghisallo Capital Management LLC0.87%$6.24M0.12%Not reported
Northern Trust Corp0.86%$6.15M0.00%Not reported
Wildcat Capital Management, LLC0.85%$6.08M2.66%Not reported
Charles Schwab Investment Management Inc0.66%$4.73M0.00%Not reported
AQR Capital Management LLC0.58%$4.17M0.00%Not reported
DAFNA Capital Management LLC0.58%$4.16M0.79%Add 45.97%
Vanguard Fiduciary Trust Co0.53%$3.82M0.00%Not reported
Boxer Capital Management, LLC0.43%$3.12M0.24%Reduce 44.95%
Jacobs Levy Equity Management, Inc0.42%$3.03M0.01%Not reported
JPMorgan Chase & Co0.42%$3.19M0.00%Not reported
Invesco Ltd.0.22%$1.61M0.00%Not reported
Bank of New York Mellon Corp0.21%$1.51M0.00%Not reported
Hennion & Walsh Asset Management, Inc.0.21%$1.5M0.04%New Not reported
Man Group plc0.20%$1.46M0.00%Not reported
Raymond James Financial Inc0.20%$1.41M0.00%Not reported
Nuveen, LLC0.18%$1.3M0.00%Not reported
Ieq Capital, LLC0.17%$1.21M0.01%Not reported
Mitsubishi UFJ Asset Management Co., Ltd.0.16%$1.14M0.00%Add 27.64%
Citigroup Inc0.15%$1.07M0.00%Not reported
Voleon Capital Management LP0.14%$1.01M0.02%Reduce 24.19%
Ameriprise Financial Inc0.14%$977K0.00%Not reported
Russell Investments Group, Ltd.0.13%$912K0.00%Not reported
50 of 193 holders

Activity score

Premium
0
25
50
75
100
WEAK
STRONG
Unlock

AI Activity Analysis

Premium
Coming soonAI reads of insider, institutional and company activity will appear here for Premium accounts.

Historical Activity Patterns

Premium
Historical Activity PatternsHistorical periods where multiple activity categories converged, with subsequent market performance shown for context.Unlock

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.